Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Taff who wrote (409)	2/2/1999 8:46:00 PM
From: Carter Berezay	Read Replies (3) of 792

--ALL-- This new drug direction from MBI is good news but remember the Phase I NR. That to me was very good news. What happened to the share price? It went back down into the $2.70 - $3.00 range. To us threaders this new NR is good news and on the surface the price should go up. On the other side, will the share price decrease again? The Phase I trial got ZERO media coverage. I saw nothing on it. Is this new NR the same type of news - not good enough to print? I hope MBI learned a lesson in public relations from the Phase I fiasco. They need to get their name in front of the investing public with this one if the shareholders (who want their shares to go up ) are to be satisfied. To go off in this direction is going to take major bucks from MBI. Where are these bucks going to come from? MBI is running out of money in it's bank account. My guess, a joint partnership deal will satisfy short-term and long-term money needs. Wait for it!! Carter B.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next